On Monday, Vor Biopharma Inc (NASDAQ: VOR) was 20.68%% up from the session before settling in for the closing price of $0.24. A 52-week range for VOR has been $0.13 – $1.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -38.02%. When this article was written, the company’s average yearly earnings per share was at 58.59%. With a float of $76.86 million, this company’s outstanding shares have now reached $124.85 million.
Let’s determine the extent of company efficiency that accounts for 159 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Vor Biopharma Inc (VOR) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Vor Biopharma Inc stocks. The insider ownership of Vor Biopharma Inc is 38.49%, while institutional ownership is 42.26%. The most recent insider transaction that took place on Feb 13 ’25, was worth 3,162. In this transaction CHIEF MEDICAL OFFICER of this company sold 2,227 shares at a rate of $1.42, taking the stock ownership to the 126,625 shares. Before that another transaction happened on Feb 13 ’25, when Company’s Officer proposed sale 2,227 for $1.38, making the entire transaction worth $3,073.
Vor Biopharma Inc (VOR) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 58.59% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 33.72% during the next five years compared to -38.02% drop over the previous five years of trading.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
You can see what Vor Biopharma Inc (VOR) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.44 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
Looking closely at Vor Biopharma Inc (NASDAQ: VOR), its last 5-days average volume was 9.54 million, which is a jump from its year-to-date volume of 1.76 million. As of the previous 9 days, the stock’s Stochastic %D was 60.08%.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 11.04%, which indicates a significant decrease from 54.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 147.04% in the past 14 days, which was lower than the 214.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3773, while its 200-day Moving Average is $0.8259. However, in the short run, Vor Biopharma Inc’s stock first resistance to watch stands at $0.3700. Second resistance stands at $0.4500. The third major resistance level sits at $0.5200. If the price goes on to break the first support level at $0.2200, it is likely to go to the next support level at $0.1500. Should the price break the second support level, the third support level stands at $0.0700.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
There are 124,960K outstanding shares of the company, which has a market capitalization of 36.24 million. As of now, sales total 0 K while income totals -116,914 K. Its latest quarter income was 0 K while its last quarter net income were -32,486 K.
